This paper examines the safety and efficacy of budesonide, an inhaled corticosteroid, as both an early and late-stage treatment for COVID-19. Drawing on a comprehensive review of global research, including the U.K. STOIC and PRINCIPLE trials, the Brazil TOGETHER trial, and additional studies from Saudi Arabia, Australia, and India, we provide robust evidence supporting budesonide's therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Bartlett et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from The Gazette of Medical Sciences